Fresh2 News

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Liang Zhijun

Jan 27 05:35

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Tian Honggang

Jan 27 05:32

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Pu Tianruo

Jan 27 05:31

Fresh2 | 3: Initial statement of beneficial ownership of securities-Officer Li Xiaoyu

Jan 27 05:31

Fresh2 | 3: Initial statement of beneficial ownership of securities-Director Zhao Zhigang

Jan 27 05:31

Fresh2 | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Xu Haohan

Jan 16 13:00

Fresh2 | 3: Initial statement of beneficial ownership of securities-Officer Xu Haohan

Jan 5 13:00

Fresh2 | SC 13D: Statement of acquisition of beneficial ownership by individuals-Haohan Xu(24.37%),Immensus LLC(22.53%)

Jul 28, 2023 04:10

AnPac Bio-Medical Science | SC 13G: Statement of acquisition of beneficial ownership by individuals-ST. FORTUNE GROUP LLC(12.81%),Duo Liu(12.81%)

Mar 24, 2023 18:09

AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(0.06%),Chris Chang Yu(0.06%)

Oct 13, 2022 04:45

AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(0.06%),Chris Chang Yu(0.06%)

Jun 29, 2022 18:05

AnPac Bio-Medical Science | D: Filing D

Jun 13, 2022 18:06

AnPac Bio-Medical Science | D: Filing D

Jun 13, 2022 18:04

AnPac Bio-Medical Science | D: Filing D

May 28, 2022 04:45

AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(2.69%),Chris Chang Yu(2.69%)

Feb 15, 2022 05:03

AnPac Bio-Medical Science | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Feb 16, 2021 22:22

AnPac Bio-Medical Science | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 13, 2021 04:21

AnPac Bio-Medical Science | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 12, 2021 04:19

AnPac Bio-Medical Science | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 12, 2021 04:13

AnPac Bio-Medical Science | D: Filing D

Aug 25, 2020 04:16